Why the study?
High-sensitivity cardiac troponins indicate myocardial injury, but their relationship with cardiovascular outcomes in stable CAD remains less understood.
Are elevated levels of Hs-cTnT (>14 ng/L) associated with increased risks of adverse cardiac events in patients with stable CAD?
Are elevated levels of Hs-cTnT (>14 ng/L) associated with increased risks of adverse cardiac events in patients with stable CAD?
Elevated high-sensitivity troponin T (>14 ng/L) is a significant prognostic marker for adverse outcomes, including mortality and heart failure, in patients with stable coronary artery disease.
Answers are grounded in this paper and cite their sources.
Supports hs-cTnT for risk stratification in stable CAD; leaves open whether targeted interventions improve outcomes.
BACKGROUND: High-sensitivity cardiac troponins (Hs-cTns) are reliable indicators of myocardial injury, but their relationship with cardiovascular outcomes remains less understood. This study explores the association between adverse cardiac events and Hs-cTnT levels exceeding 14 ng/L in patients with stable CAD. METHODS: statistics, and both qualitative assessment (Newcastle-Ottawa Scale) and quantitative analysis (Egger's and Beggs test, funnel plots) were conducted. CONCLUSION: Elevated levels of Hs-cTnT (>14 ng/L) are significantly associated with increased risks of RDHF and ACM in patients with stable CAD. Further large-scale prospective studies are warranted to refine risk assessment strategies and mitigate cardiovascular mortality in this population.
No takes yet. Share an insight, caveat, or question.
Desai et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: